Sulbactam-Durlobactam for Bacterial Pneumonia Gets FDA Approval
Drug Topics
MAY 24, 2023
The antibiotic, marketed as Xacduro, is indicated for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii.
Let's personalize your content